These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Clinical evaluation of cefotiam in internal medicine].
    Author: Kawamura S, Sakata Y, Chiba Y, Yoshida Y, Aizawa M, Nara H, Yanagiya S, Fukushi K, Ohmi T, Okamoto K, Komatsu Y, Haneda Y, Tanabe K, Segawa M, Yamagata A, Kawatsu S.
    Journal: Jpn J Antibiot; 1982 May; 35(5):1136-44. PubMed ID: 6290697.
    Abstract:
    Cefotiam (CTM) was administered to 52 patients with infectious disease associated with respiratory system, hematological malignancy, urinary system and other system. Good clinical responses were obtained in 38 out of 52 cases (73.1%). Neither objective and subjective side effects nor extreme abnormalities of laboratory tests were observed in these patients. It can be, therefore, concluded that CTM is 1 of the most useful drugs for infectious diseases in respiratory system, hematological malignancy, urinary system and other system.
    [Abstract] [Full Text] [Related] [New Search]